Healthcare provider profile · identity verified

Larry Travis Heap, PA-C

Physician Assistant · EAGAR, AZ · NPI 1366418113

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	454	120
Levothyroxine Sodium	Levothyroxine Sodium	424	103
Lisinopril	Lisinopril	374	87
Metformin Hcl	Metformin Hcl	278	73
Losartan Potassium	Losartan Potassium	257	68
Amlodipine Besylate	Amlodipine Besylate	214	56
Hydrochlorothiazide	Hydrochlorothiazide	208	60
Gabapentin	Gabapentin	182	49
Metoprolol Tartrate	Metoprolol Tartrate	174	38
Omeprazole	Omeprazole	172	39
Pantoprazole Sodium	Pantoprazole Sodium	158	43
Tamsulosin Hcl	Tamsulosin Hcl	137	37
Furosemide	Furosemide	123	36
Alendronate Sodium	Alendronate Sodium	106	21
Rosuvastatin Calcium	Rosuvastatin Calcium	106	23
Allopurinol	Allopurinol	105	21
Potassium Chloride	Potassium Chloride	101	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	98	24
Albuterol Sulfate Hfa	Albuterol Sulfate	97	29
Trazodone Hcl	Trazodone Hcl	96	28
Metoprolol Succinate	Metoprolol Succinate	92	23
Zolpidem Tartrate	Zolpidem Tartrate	91	11
Simvastatin	Simvastatin	89	17
Famotidine	Famotidine	87	26
Clopidogrel	Clopidogrel Bisulfate	85	23
Escitalopram Oxalate	Escitalopram Oxalate	85	13
Finasteride	Finasteride	77	16
Fluticasone Propionate	Fluticasone Propionate	77	38
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	77	19
Warfarin Sodium	Warfarin Sodium	77	14
Montelukast Sodium	Montelukast Sodium	74	26
Atenolol	Atenolol	72	14
Duloxetine Hcl	Duloxetine Hcl	70	19
Sertraline Hcl	Sertraline Hcl	69	16
Celecoxib	Celecoxib	65	19
Tramadol Hcl	Tramadol Hcl	63	17
Pravastatin Sodium	Pravastatin Sodium	62	15
Lovastatin	Lovastatin	60	11
Doxazosin Mesylate	Doxazosin Mesylate	59	12
Eliquis	Apixaban	57	20
Synthroid	Levothyroxine Sodium	56	15
Fluoxetine Hcl	Fluoxetine Hcl	55	11
Pregabalin	Pregabalin	50	11
Acyclovir	Acyclovir	46	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	suppressed
Meloxicam	Meloxicam	43	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	suppressed
Ezetimibe	Ezetimibe	41	suppressed
Ozempic	Semaglutide	41	suppressed
Donepezil Hcl	Donepezil Hcl	39	11
Prednisone	Prednisone	38	26
Fenofibrate	Fenofibrate	37	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	36	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Cephalexin	Cephalexin	32	23
Ibuprofen	Ibuprofen	31	suppressed
Lansoprazole	Lansoprazole	31	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Glimepiride	Glimepiride	28	suppressed
Topiramate	Topiramate	28	suppressed
Baclofen	Baclofen	27	13
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Carvedilol	Carvedilol	26	11
Jardiance	Empagliflozin	26	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Azithromycin	Azithromycin	24	24
Glipizide	Glipizide	24	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	21
Spironolactone	Spironolactone	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Naproxen	Naproxen	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	20	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Methotrexate	Methotrexate Sodium	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	12
Terazosin Hcl	Terazosin Hcl	18	suppressed
Carisoprodol	Carisoprodol	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	15
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	16	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Valsartan	Valsartan	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Estradiol	Estradiol	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error